Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-109782
Filing Date
2025-11-12
Accepted
2025-11-12 07:46:01
Documents
124
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20250930x10q.htm   iXBRL 10-Q 3743086
2 EX-31.1 xoma-20250930xex31d1.htm EX-31.1 13990
3 EX-31.2 xoma-20250930xex31d2.htm EX-31.2 14010
4 EX-32.1 xoma-20250930xex32d1.htm EX-32.1 8598
  Complete submission text file 0001104659-25-109782.txt   17103721

Data Files

Seq Description Document Type Size
5 EX-101.SCH xoma-20250930.xsd EX-101.SCH 128580
6 EX-101.CAL xoma-20250930_cal.xml EX-101.CAL 112985
7 EX-101.DEF xoma-20250930_def.xml EX-101.DEF 648091
8 EX-101.LAB xoma-20250930_lab.xml EX-101.LAB 937960
9 EX-101.PRE xoma-20250930_pre.xml EX-101.PRE 888371
127 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20250930x10q_htm.xml XML 3327744
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 251468933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)